Bone mineral status in 134 patients with cystic fibrosis

Archives of Disease in Childhood

Volumn 81, Issue 3, 1999, Pages 235-240

  Laursen, E M ^a,c   Molgaard C ^b   Michaelsen, K F ^b   Koch, C ^d   Muller J ^a  

^a International Center for Research and Research Training in Endocrine Disruption of Male Reproduction and Child Health   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c NONE   (Denmark)

^d NONE

Author keywords

Bone mineral content; Bone mineral density; Cystic fibrosis

Indexed keywords

CALCIUM; VITAMIN D;

ABSORPTIOMETRY; ADOLESCENT; ADULT; ARTICLE; BONE DENSITY; BONE MINERAL; CHILD; CONTROLLED STUDY; CYSTIC FIBROSIS; DIET SUPPLEMENTATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OSTEOPOROSIS; PATHOLOGIC FRACTURE; PRIORITY JOURNAL;

EID: 0032766241     PISSN: 00039888     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/adc.81.3.235     Document Type: Article

References (21)

1. Frederiksen B, Lanng S, Koch C, Hoiby N. Improved survival in the Danish center-treated cystic fibrosis patients: results of aggressive treatment. Pediatr Pulmonol 1996;21:153-8.
2. Henderson RC, Madsen CD. Bone density in children and adolescents with cystic fibrosis. J Pediatr 1996;128:28-34.
3. Bachrach LK, Loutit CW, Mos RB, Marcus R. Osteopenia in adults with cystic fibrosis. Am J Med 1994;96:27-34.
4. Shane E, Silverberg SJ, Donovan D, et al. Osteoporosis in lung transplantation candidates with end-stage pulmonary disease. Am J Med 1996;101:262-9.
5. Grey AB, Ames RW, Matthews RD, Reid IR. Bone mineral density and body composition in adult patients with cystic fibrosis. Thorax 1993;48:589-93.
6. Aris RM, Neuringer IP, Weiner MA, Egan TM, Ontjes D. Severe osteoporosis before and after lung transplantation. Ghest 1996;109:1176-83.
7. Karlberg J, Kjellmer I, Kristiansson B. Linear growth in children with cystic fibrosis. I. Birth to 8 years of age. Acta Paediatr Scand 1991;80:508-14.
8. Soutter VL, Kristidis P, Gruca MA, Gaskin KJ. Chronic undernutrition/growth retardation in cystic fibrosis. Clin Gastroenterol 1986;15:137-55.
9. Barkhouse LB, Fahey J, Gillespie CT, Cole DE. Quantitating the effect of cystic fibrosis on linear growth by mathematical modelling of longitudinal growth curves. Growth Dev Aging 1989;53:185-90.
10. Haeusler G, Frisch H, Waldhor T, Gotz M. Perspectives of longitudinal growth in cystic fibrosis from birth to adult age. Eur J Pediatr 1994;153:158-63.
11. Prentice A, Parsons TJ, Cole TJ. Uncritical use of bone mineral density in absorptiometry may lead to size-related artifacts in the identification of bone mineral determinants. Am J Clin Nutr 1994;60:837-42.
12. Bhudhikanok GS, Lim J, Marcus R, Harkins A, Moss RB, Bachrach LK. Correlates of osteopenia in patients with cystic fibrosis. Pediatrics 1996;97:103-11.
13. Salamoni F, Roulet M, Gudinchet F, Pilet M, Thiébaud D, Burckhardt P. Bone mineral content in cystic fibrosis patients: correlation with fat-free mass. Arch Dis Child 1996;74:314-18.
14. Schwartz M, Johansen HK, Koch C, Brandt NJ. Frequency of the delta F508 mutation on cystic fibrosis chromosomes in Denmark. Hum Genet 1991;85:427-8.
15. Moølgaard C, Thomsen BL, Prentice A, Cole TJ, Michaelsen KF. Whole body bone mineral content in healthy children and adolescents. Arch Dis Child 1997;76:9-15.
16. WHO Study Group. Diabetes mellitus. World Health Organ Tech Rep Ser 1985;727:1-113.
17. Polgar G, Promadhat V. Pulmonary function testing in children: techniques and standards. Philadelphia: WB Saunders, 1971.
18. Hoøtby N, Axelsen NH. Identification and quantitation of precipitins against Pseudomonas aeruginosa in patients with cystic fibrosis by means of crossed immunoelectrophoresis with intermediate gel. Acta Pathol Microbiol Scand 1973;81:298-308.
19. Baroncelli GI, De Luca F, Magazzu G, et al. Bone demineralízation in cystic fibrosis: evidence of imbalance between bone formation and degradation. Pediatr Res 1997;41:397-403.
20. Cummings SR, Black DM, Nevitt MC, et al. Bone density at various sites for prediction of hip fractures. Lancet 1993;341:72-5.
21. World health Organisation. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. WHO report 843. Geneva: WHO, 1994.